Edwards Lifesciences
In AKO Capital's portfolio · London
Ticker EW
Not in the portfolio as of Q3 2026. Every quarter it shows up in a London 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2020 | Sell | 0 | |
| Q1 2020 | Reduce 9% | 753,568 | 3.0% |
| Q4 2019 | Add 29% | 828,423 | 4.2% |
| Q3 2019 | Add 13% | 643,499 | 3.4% |
| Q2 2019 | Add 24% | 570,254 | 2.7% |
| Q1 2019 | Add 65% | 458,351 | 2.6% |
| Q4 2018 | Add 28% | 278,181 | 1.9% |
| Q3 2018 | Reduce 10% | 217,812 | 1.9% |
| Q2 2018 | Buy | 243,336 | 1.9% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.